| Basic and Diluted Earnings Per Share |
The basic and diluted EPS are calculated as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2023 | | 2022 | | 2023 | | 2022 | | EPS - basic | | | | | | | | | Net income (loss) attributable to Green Plains | $ | 22,311 | | | $ | (73,526) | | | $ | (100,617) | | | $ | (88,602) | | | Weighted average shares outstanding - basic | 58,910 | | | 57,677 | | | 58,780 | | | 54,550 | | | EPS - basic | $ | 0.38 | | | $ | (1.27) | | | $ | (1.71) | | | $ | (1.62) | | | | | | | | | | | EPS - diluted | | | | | | | | | Net income (loss) attributable to Green Plains | $ | 22,311 | | | $ | (73,526) | | | $ | (100,617) | | | $ | (88,602) | | Interest and amortization on 2.25% convertible notes due 2027, net of tax effect | 1,201 | | | — | | | — | | | — | | | Net income (loss) attributable to Green Plains - diluted | $ | 23,512 | | | $ | (73,526) | | | $ | (100,617) | | | $ | (88,602) | | | | | | | | | | | Weighted average shares outstanding - basic | 58,910 | | | 57,677 | | | 58,780 | | | 54,550 | | Effect of dilutive 2.25% convertible notes due 2027 | 7,273 | | | — | | | — | | | — | | | Effect of dilutive warrants | 837 | | | — | | | — | | | — | | | Effect of dilutive stock-based compensation awards | 382 | | | — | | | — | | | — | | | Weighted average shares outstanding - diluted | $ | 67,402 | | | $ | 57,677 | | | $ | 58,780 | | | $ | 54,550 | | | EPS - diluted | $ | 0.35 | | | $ | (1.27) | | | $ | (1.71) | | | $ | (1.62) | | | | | | | | | | Anti-dilutive weighted-average convertible debt, warrants and stock-based compensation (1) | — | | | 8,660 | | | 8,516 | | | 8,571 | |
(1)For the nine months ended September 30, 2023, the effects related to the company’s 2.25% convertible notes due in 2027, warrants and certain stock-based compensation awards have been excluded from diluted EPS as the inclusion of these shares would have been anti-dilutive. For the three and nine months ended September 30, 2022, the effects related to the company's 2.25% convertible notes due in 2027, warrants and certain stock-based compensation awards were excluded from diluted EPS as the inclusion of these shares would have been anti-dilutive.
|